Effects of Lurasidone on Left Ventricle Systolic Functions
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorAydin Adnan Menderes University
About this trial
The goal of our study to learn if lurasidone molecule which is used on patients with schizophrenia or bipolar disorder has any cardiotoxic effect.
Eligibility criteria
Qualifiers
Aged 18 to 65 years
Diagnosed with schizophrenia or bipolar disorder by the psychiatry clinic of our center and indicated to use lurasidone molecule
Hasn't been diagnosed with coronary artery disease, any kind of heart failure or severe valvular disease
Disqualifiers
Patients who do not agree to participate to the trial
Patient who do not meet the inclusion criteria
Trial design
Treatments tested in this trial
- Global Longitudinal Strain
Treatment groups
62 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov